ResMed | RMD - Eigenkapital Und Reserven

Aktienkurs
252.43
Täglich Wechseln
-2.89 -1.13%
Monatlich
-8.53%
Jährlich
8.60%
Q1 Prognose
248.42




Eigenkapital Und Reserven Veränderung Datum
Ansell USD 1.97B 10.2M 2025-12
Artivion USD 438.69M 18.79M 2025-09
AtriCure USD 491.94M 15.43M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Cochlear AUD 1.94B 12.2M 2025-12
Cooper Companies USD 8.24B 113.7M 2025-09
CSL USD 18.66B 2.75B 2025-12
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Fisher Paykel Healthcare NZD 1.99B 95.8M 2025-12
Globus Medical USD 4.57B 174.42M 2025-12
Haemonetics USD 911.45M 62.28M 2025-12
Hologic USD 5.25B 197.2M 2025-12
Idexx Laboratories USD 1.61B 44.2M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 5.89M 2025-12
Intuitive Surgical USD 17.82B 894.3M 2025-12
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.86B 964M 2025-09
Philips EUR 10.58B 204M 2025-09
Ramsay Health Care AUD 4.79B 916.1M 2025-12
ResMed USD 6.32B 199.61M 2025-12
Sigma Healthcare AUD 4.67B 3.8B 2025-12
Sonic Healthcare AUD 8.2B 120.9M 2024-12
Steris USD 7.15B 145.4M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12